Frits A. Wijburg

18.9k total citations · 1 hit paper
282 papers, 11.5k citations indexed

About

Frits A. Wijburg is a scholar working on Physiology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Frits A. Wijburg has authored 282 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Physiology, 95 papers in Clinical Biochemistry and 84 papers in Molecular Biology. Recurrent topics in Frits A. Wijburg's work include Lysosomal Storage Disorders Research (109 papers), Metabolism and Genetic Disorders (95 papers) and Trypanosoma species research and implications (48 papers). Frits A. Wijburg is often cited by papers focused on Lysosomal Storage Disorders Research (109 papers), Metabolism and Genetic Disorders (95 papers) and Trypanosoma species research and implications (48 papers). Frits A. Wijburg collaborates with scholars based in Netherlands, United Kingdom and United States. Frits A. Wijburg's co-authors include Ronald J. A. Wanders, Carla E. M. Hollak, Lodewijk IJlst, Ben J. H. M. Poorthuis, Gabor E. Linthorst, M. J. Valstar, Johannes M. F. G. Aerts, Hans R. Waterham, Annet M. Bosch and John J.P. Kastelein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Frits A. Wijburg

277 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elevated globotriaosylsphingosine is a hallmark of Fabry disease

2008 566 citations Frits A. Wijburg, Gabor E. Linthorst et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frits A. Wijburg Netherlands	60	6.1k	4.1k	2.9k	2.3k	1.6k	282	11.5k
Barbara K. Burton United States	50	3.2k 0.5×	2.9k 0.7×	2.8k 1.0×	1.0k 0.5×	1.3k 0.8×	248	7.7k
Generoso Andria Italy	46	2.3k 0.4×	2.9k 0.7×	1.3k 0.5×	1.1k 0.5×	2.6k 1.6×	215	8.5k
Giancarlo Parenti Italy	44	3.5k 0.6×	3.4k 0.8×	635 0.2×	2.4k 1.1×	1.4k 0.9×	203	9.0k
Priya S. Kishnani United States	56	7.6k 1.3×	2.6k 0.6×	1.1k 0.4×	2.2k 1.0×	6.4k 4.0×	456	12.8k
Carla E. M. Hollak Netherlands	65	10.1k 1.7×	4.5k 1.1×	896 0.3×	4.1k 1.8×	1.7k 1.0×	296	12.8k
Alberto Burlina Italy	49	2.8k 0.5×	3.9k 1.0×	4.5k 1.6×	466 0.2×	1.5k 0.9×	234	8.0k
Carlo Dionisi‐Vici Italy	50	1.7k 0.3×	4.9k 1.2×	4.6k 1.6×	587 0.3×	1.5k 0.9×	292	9.3k
Hanna Mandel Israel	43	1.8k 0.3×	4.0k 1.0×	2.4k 0.8×	545 0.2×	1.4k 0.9×	176	7.4k
Dietrich Matern United States	47	1.8k 0.3×	3.5k 0.9×	3.5k 1.2×	632 0.3×	1.1k 0.7×	180	6.7k
Robert D. Steiner United States	45	1.5k 0.3×	2.6k 0.6×	1.1k 0.4×	946 0.4×	994 0.6×	201	6.8k

Countries citing papers authored by Frits A. Wijburg

Since Specialization

Citations

This map shows the geographic impact of Frits A. Wijburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frits A. Wijburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frits A. Wijburg more than expected).

Fields of papers citing papers by Frits A. Wijburg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frits A. Wijburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frits A. Wijburg. The network helps show where Frits A. Wijburg may publish in the future.

Co-authorship network of co-authors of Frits A. Wijburg

This figure shows the co-authorship network connecting the top 25 collaborators of Frits A. Wijburg. A scholar is included among the top collaborators of Frits A. Wijburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frits A. Wijburg. Frits A. Wijburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brands, Marion M., Lotte Haverman, Caroline B. Terwee, et al.. (2024). Navigating the outcome maze: a scoping review of outcomes and instruments in clinical trials in genetic neurodevelopmental disorders and intellectual disability. PubMed. 5. 931155481–931155481. 5 indexed citations

Bugiani, Marianna, Truus E. M. Abbink, Arthur W. D. Edridge, et al.. (2023). Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA. Annals of Clinical and Translational Neurology. 10(6). 904–917. 6 indexed citations

Wijburg, Frits A., Stewart Rust, Jessica de Ruijter, et al.. (2021). Long-term safety and clinical outcomes of intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A. Molecular Genetics and Metabolism. 134(4). 317–322. 6 indexed citations

Garrelfs, Sander F., Hessel Peters‐Sengers, Chris H.P. van den Akker, et al.. (2021). Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients. Journal of the American Society of Nephrology. 32(12). 3175–3186. 13 indexed citations

Haverman, Lotte, et al.. (2021). Preconception expanded carrier screening: a focus group study with relatives of mucopolysaccharidosis type III patients and the general population. Journal of Community Genetics. 12(3). 311–323. 5 indexed citations

Knottnerus, Suzan J. G., Isabella Mengarelli, Rob C. I. Wüst, et al.. (2020). Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates. International Journal of Molecular Sciences. 21(7). 2589–2589. 24 indexed citations

Knottnerus, Suzan J. G., Henk Schierbeek, Jeannette C. Bleeker, et al.. (2020). Exploring the metabolic fate of medium-chain triglycerides in healthy individuals using a stable isotope tracer. Clinical Nutrition. 40(3). 1396–1404. 11 indexed citations

Bleeker, Jeannette C., Sacha Ferdinandusse, Maaike de Vries, et al.. (2019). Proposal for an individualized dietary strategy in patients with very long‐chain acyl‐CoA dehydrogenase deficiency. Journal of Inherited Metabolic Disease. 42(1). 159–168. 18 indexed citations

Clarke, L., Roberto Giugliani, Nathalie Guffon, et al.. (2019). Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry. Clinical Genetics. 96(4). 281–289. 51 indexed citations

10.

Hasselt, Peter M. van, et al.. (2017). Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation. Molecular Genetics and Metabolism. 122(1-2). 86–91. 4 indexed citations

11.

Ofman, Rob, Inge M. E. Dijkstra, Frits A. Wijburg, et al.. (2017). Lipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(9). 2255–2265. 37 indexed citations

12.

Arends, Maarten, Christoph Wanner, Derralynn Hughes, et al.. (2016). Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study. Journal of the American Society of Nephrology. 28(5). 1631–1641. 266 indexed citations

13.

Jones, Simon, Catherine Breen, Stewart Rust, et al.. (2016). A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA. Molecular Genetics and Metabolism. 118(3). 198–205. 83 indexed citations

14.

Langereis, Eveline J., Tom Wagemans, Wim Kulik, et al.. (2015). A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses. PLoS ONE. 10(9). e0138622–e0138622. 30 indexed citations

15.

Ruijter, Jessica de, Lodewijk IJlst, Wim Kulik, et al.. (2012). Heparan sulfate derived disaccharides in plasma and total urinary excretion of glycosaminoglycans correlate with disease severity in Sanfilippo disease. Journal of Inherited Metabolic Disease. 36(2). 271–279. 23 indexed citations

16.

Derks, Terry G. J., et al.. (2011). PRESENTATION OF AN ACQUIRED INHERITED UREA CYCLE DISORDER LIVER TRANSPLANTATION FROM A DONOR WITH ORNITHINE TRANSCARBAMYLASE DEFICIENCY. Journal of Inherited Metabolic Disease. 34. 1 indexed citations

17.

Woerden, Christiaan S. van, Jaap W. Groothoff, Frits A. Wijburg, et al.. (2006). High incidence of hyperoxaluria in generalized peroxisomal disorders. Molecular Genetics and Metabolism. 88(4). 346–350. 15 indexed citations

18.

Triepels, Ralf, Lambertus P. van den Heuvel, Jan Loeffen, et al.. (1999). Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Annals of Neurology. 45(6). 787–790. 164 indexed citations

19.

Oostra, Roelof‐Jan, et al.. (1995). [Leber's optic nerve atrophy; a mitochondrial hereditary disease].. PubMed. 139(26). 1327–31. 2 indexed citations

20.

Wijburg, Frits A., David S. Rosenblatt, Gijs D. Vos, et al.. (1992). Clinical and biochemical observations in a patient with combined Pompe disease and cblC mutation. European Journal of Pediatrics. 151(2). 127–131. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact